Summary
- French drugmaker Sanofi collaborates with OpenAI and Formation Bio for AI-driven drug development.
- Access to proprietary data for developing AI models.
- Aim to accelerate drug development and potentially save costs.
- Utilizing artificial intelligence to enhance drug development processes.
